Parisa Zamiri
Net worth: 119 841 $ as of 2024-03-30
Profile
Parisa Zamiri worked as the Director-Pre-Clinical Sciences at Arsenal Medical, Inc. from 2007 to 2011.
She then served as the VP & Global Head-Clinical Development at Novartis AG from 2012 to 2020.
Dr. Zamiri was the Chief Medical Officer at Graybug Vision, Inc. from 2020 to 2023.
She also held the position of Chief Medical Officer at CalciMedica, Inc. Dr. Zamiri holds a doctorate degree from University College London and a graduate degree from King's College London.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CALCIMEDICA, INC.
0.27% | 2023-03-22 | 28,808 ( 0.27% ) | 119 841 $ | 2024-03-30 |
Former positions of Parisa Zamiri
| Companies | Position | End |
|---|---|---|
| CALCIMEDICA, INC. | Chief Tech/Sci/R&D Officer | 2023-02-27 |
| CALCIMEDICA, INC. | Chief Tech/Sci/R&D Officer | 2023-02-27 |
| NOVARTIS AG | Corporate Officer/Principal | 2020-05-31 |
Arsenal Medical, Inc.
 Arsenal Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Arsenal Medical Inc. develops therapeutic products based on BioActive Composites platform. Its biomaterials-based systems provide targeted local and systemic therapies to treat chronic diseases and conditions. The firm product offers tailored dosing of drugs, mechanical and biochemical compatibility with tissues and complete bioabsorption. The company was founded by George M. Whitesides, Carmichael S. Roberts Jr. and Robert S. Langer Jr. in 2005 and is headquartered in Watertown, MA. | Corporate Officer/Principal | 2011-10-31 |
Training of Parisa Zamiri
| University College London | Doctorate Degree |
| King's College London | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| NOVARTIS AG | Health Technology |
| CALCIMEDICA, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Arsenal Medical, Inc.
Arsenal Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Arsenal Medical Inc. develops therapeutic products based on BioActive Composites platform. Its biomaterials-based systems provide targeted local and systemic therapies to treat chronic diseases and conditions. The firm product offers tailored dosing of drugs, mechanical and biochemical compatibility with tissues and complete bioabsorption. The company was founded by George M. Whitesides, Carmichael S. Roberts Jr. and Robert S. Langer Jr. in 2005 and is headquartered in Watertown, MA. | Commercial Services |
Graybug Vision, Inc.
 Graybug Vision, Inc. Pharmaceuticals: MajorHealth Technology Graybug Vision, Inc. develops ophthalmic drugs. It focus on developing drug delivery therapies for the treatment of eye diseases such as age-related macular degeneration and glaucoma. The company was founded by Justin S. Hanes, Peter John McDonnell, Christy Wyskiel and Peter A. Campochiaro in May 2011 and is headquartered in Redwood City, CA. | Health Technology |
- Stock Market
- Insiders
- Parisa Zamiri